ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Recent Registrations
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
January - February - March - April - May - June - July - August - September - Oktober - November - December | 2002 - 2003 - 2004 - 2005 - 2006 - 2007 - 2008 - 2009 - 2010 - 2011 - 2012 - 2013 - 2014 - 2015 - 2016 - 2017 - 2018 - 2019 - 2020 - 2021 - 2022 - 2023 - 2024 - 2025 - 2026
February 2022 - 54 products
L IPCI Icatibant Spirig HC 30 mg3 ml726.15806.1510 %Injection solution in prefilled syringe: Icatibantum 30mg / 3mlSpirig HealthCare AG● B / SL / SGG
L IPCI Etoricoxib Zentiva 30 mg2813.9931.6510 %Coated tablets: Etoricoxibum 30 mgHelvepharm AGB / SL / SGG
L IPCI Etoricoxib Zentiva 60 mg75.5515.3010 %Coated tablets: Etoricoxibum 60 mgHelvepharm AG● B / SL / SGG
L IPCI Etoricoxib Zentiva 60 mg2822.2140.6010 %Coated tablets: Etoricoxibum 60 mgHelvepharm AGB / SL / SGG
L IPCI Ezetimib-Atorvastatin-
Mepha 10/10 mg		3019.8338.0010 %Coated tablets: 2 Active AgentsMepha Pharma AGB / SL / SGG
L IPCI Ezetimib-Atorvastatin-
Mepha 10/10 mg		9059.5081.1510 %Coated tablets: 2 Active AgentsMepha Pharma AGB / SL / SGG
L IPCI Ezetimib-Atorvastatin-
Mepha 10/20 mg		3019.8338.0010 %Coated tablets: 2 Active AgentsMepha Pharma AGB / SL / SGG
L IPCI Ezetimib-Atorvastatin-
Mepha 10/20 mg		9059.5081.1510 %Coated tablets: 2 Active AgentsMepha Pharma AGB / SL / SGG
L IPCI Ezetimib-Atorvastatin-
Mepha 10/40 mg		3019.8338.0010 %Coated tablets: 2 Active AgentsMepha Pharma AGB / SL / SGG
L IPCI Ezetimib-Atorvastatin-
Mepha 10/40 mg		9059.5081.1510 %Coated tablets: 2 Active AgentsMepha Pharma AGB / SL / SGG
L IPCI Ezetimib-Atorvastatin-
Mepha 10/80 mg		3019.8338.0010 %Coated tablets: 2 Active AgentsMepha Pharma AGB / SL / SGG
L IPCI Ezetimib-Atorvastatin-
Mepha 10/80 mg		9059.5081.1510 %Coated tablets: 2 Active AgentsMepha Pharma AGB / SL / SGG
L IPCI Zonisamid Sandoz 25 mg148.0325.1510 %Capsules: Zonisamidum 25 mgSandoz
Pharmaceuticals AG		B / SL / SGG
L IPCI Zonisamid Sandoz 50 mg5643.7063.9510 %Capsules: Zonisamidum 50 mgSandoz
Pharmaceuticals AG		B / SL / SGG
L IPCI Zonisamid Sandoz 100 mg5670.2292.8010 %Capsules: Zonisamidum 100 mgSandoz
Pharmaceuticals AG		B / SL / SGG
L IPCI Zonisamid Sandoz 100 mg98120.98148.0010 %Capsules: Zonisamidum 100 mgSandoz
Pharmaceuticals AG		B / SL / SGG
L IPCI Ezetimib Atorvastatin
Sandoz 10 mg / 10 mg		3020.0838.2510 %Filmtablette: 2 Active AgentsSandoz
Pharmaceuticals AG		B / SL / SGG
L IPCI Ezetimib Atorvastatin
Sandoz 10 mg / 10 mg		9060.2481.9010 %Filmtablette: 2 Active AgentsSandoz
Pharmaceuticals AG		B / SL / SGG
L IPCI Ezetimib Atorvastatin
Sandoz 10 mg / 20 mg		3020.0838.2510 %Filmtablette: 2 Active AgentsSandoz
Pharmaceuticals AG		B / SL / SGG
L IPCI Ezetimib Atorvastatin
Sandoz 10 mg / 20 mg		9060.2481.9010 %Filmtablette: 2 Active AgentsSandoz
Pharmaceuticals AG		B / SL / SGG
L IPCI Ezetimib Atorvastatin
Sandoz 10 mg / 40 mg		3020.0838.2510 %Filmtablette: 2 Active AgentsSandoz
Pharmaceuticals AG		B / SL / SGG
L IPCI Ezetimib Atorvastatin
Sandoz 10 mg / 40 mg		9060.2481.9010 %Filmtablette: 2 Active AgentsSandoz
Pharmaceuticals AG		B / SL / SGG
L IPCI Ezetimib Atorvastatin
Sandoz 10 mg / 80 mg		3020.0838.2510 %Filmtablette: 2 Active AgentsSandoz
Pharmaceuticals AG		B / SL / SGG
L IPCI Ezetimib Atorvastatin
Sandoz 10 mg / 80 mg		9060.2481.9010 %Filmtablette: 2 Active AgentsSandoz
Pharmaceuticals AG		● B / SL / SGG
L IPCI Sapropterin Dipharma 100 mg30487.12567.3010 %compressa dispersibile: Sapropterini Dihydrochloridum 100 mgDipharma SAB / SL / SGG
L IPCI Sapropterin Dipharma 100 mg1201948.502135.5510 %compressa dispersibile: Sapropterini Dihydrochloridum 100 mgDipharma SAB / SL / SGG
L IPCIV/SCutaquig 165 mg/ml 66.5088.7510 %Injection solution: Immunoglobulinum Humanum Normale 165 mg/mlOctapharma AGB / SLG
L IPCIV/SCutaquig 165 mg/ml 133.00161.0510 %Injection solution: Immunoglobulinum Humanum Normale 165 mg/mlOctapharma AGB / SLG
L IPCIV/SCutaquig 165 mg/ml 266.00305.7010 %Injection solution: Immunoglobulinum Humanum Normale 165 mg/mlOctapharma AGB / SLG
L IPCIV/SCutaquig 165 mg/ml 532.00595.0010 %Injection solution: Immunoglobulinum Humanum Normale 165 mg/mlOctapharma AGB / SLG
L IPCIV/SCutaquig 165 mg/ml10665.00739.6510 %Injection solution: Immunoglobulinum Humanum Normale 165 mg/mlOctapharma AGB / SLG
L IPCIV/SCutaquig 165 mg/ml101330.001462.8510 %Injection solution: Immunoglobulinum Humanum Normale 165 mg/mlOctapharma AGB / SLG
L IPCIV/SCutaquig 165 mg/ml102660.002909.3510 %Injection solution: Immunoglobulinum Humanum Normale 165 mg/mlOctapharma AGB / SLG
L IPCIV/SCutaquig 165 mg/ml105320.005766.1010 %Injection solution: Immunoglobulinum Humanum Normale 165 mg/mlOctapharma AGB / SLG
L IPCI Adtralza 150mg/ml4978.301080.4010 %Injection solution in prefilled syringe: Tralokinumabum 150 mg/mlLEO Pharmaceutical
Products Sarath Ltd.		B / SLG
L IP  Jemperli 500 mg/10 ml 4472.744880.8010 %Concentrate for infusion: Dostarlimabum 500mg / 10mlGlaxoSmithKline AGA / SLG
L IPCI Klisyri546.5867.0510 %Ointment: Tirbanibulinum 10 mgAlmirall AGA / SLG
L IPCI Lundeos44.2813.9010 %Soft capsules: Cholecalciferolum 20000 UILabatec Pharma SAB / SLG
L IPCI Lecigon7 x 47 ml374.40423.6010 %Gel for intestinal application: 3 Active AgentsSpirig HealthCare AGB / SLG
L IPCI Cosentyx UnoReady 300 mg / 2 ml 1074.571185.1010 %Injektionslösung im Fertigpen: Secukinumabum 300mg / 2mlNovartis Pharma
Schweiz AG		B / SLG
  IPCI Burn-X7k.A.Gastric juice resistant tablets: Esomeprazolum 20 mgaxapharm agDG
  IPCI Burn-X14k.A.Gastric juice resistant tablets: Esomeprazolum 20 mgaxapharm agDG
  IPCI Lundeos2 x 4k.A.Soft capsules: Cholecalciferolum 20000 UILabatec Pharma SABG
  IP  Vyxeos liposomal 44
mg/100 mg		 k.A.Pulver für ein Konzentrat zur Herstellung einer Infusionsdispersion: 2 Active AgentsMEDA Pharmaceuticals
Switzerland GmbH		AG
  IP  Vyxeos liposomal 44
mg/100 mg		2k.A.Pulver für ein Konzentrat zur Herstellung einer Infusionsdispersion: 2 Active AgentsMEDA Pharmaceuticals
Switzerland GmbH		AG
  IP  Vyxeos liposomal 44
mg/100 mg		5k.A.Pulver für ein Konzentrat zur Herstellung einer Infusionsdispersion: 2 Active AgentsMEDA Pharmaceuticals
Switzerland GmbH		AG
  IPCI Rennie Gum20k.A.Wirkstoffhaltiger Kaugummi: Calcii Carbonas 750 mgBayer (Schweiz) AGDG
  IPCI Rhinisone 50 μg140k.A.suspension pour pulvérisation nasale: Mometasoni FuroasLeman SKL SAG
L IPCI Brukinsa 80 mg1204288.854680.8010 %Capsules: Zanubrutinibum 80 mgBeOne Medicines I
GmbH		A / SLG
  IPCIV/SCutaquig 165 mg/ml20k.A.Injection solution: Immunoglobulinum Humanum Normale 165 mg/mlOctapharma AGBG
  IPCIV/SCutaquig 165 mg/ml20k.A.Injection solution: Immunoglobulinum Humanum Normale 165 mg/mlOctapharma AGBG
  IPCIV/SCutaquig 165 mg/ml20k.A.Injection solution: Immunoglobulinum Humanum Normale 165 mg/mlOctapharma AGBG
  IPCIV/SCutaquig 165 mg/ml20k.A.Injection solution: Immunoglobulinum Humanum Normale 165 mg/mlOctapharma AGBG
  IPCI Rhinisone 50 μg3 x 140k.A.suspension pour pulvérisation nasale: Mometasoni FuroasLeman SKL SABG
 show caption
 
ATC-Browser | Drugs A-Z | Recent Registrations
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home